imipramine and 6-methyl-2-(phenylethynyl)pyridine

imipramine has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chojnacka-Wójcik, E; Gasparini, F; Klodzińska, A; Kuhn, R; Palucha, A; Pilc, A; Tatarczyńska, E1
Bianchi, M; Cavanni, P; Crespi, F; Faedo, S; Heidbreder, CA; Lacroix, LP; Perdona, E; Remelli, R1
Belozertseva, IV; Bespalov, AY; Danysz, W; Kos, T; Popik, P1
Baez, M; Li, X; Need, AB; Witkin, JM1
Niedzielska, E; Nowak, G; Pałucha-Poniewiera, A; Pilc, A; Pomierny, B; Pomierny-Chamioło, L; Siwek, A1

Other Studies

5 other study(ies) available for imipramine and 6-methyl-2-(phenylethynyl)pyridine

ArticleYear
Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
    British journal of pharmacology, 2001, Volume: 132, Issue:7

    Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Imipramine; Male; Maze Learning; Mice; Mice, Inbred C57BL; Psychomotor Performance; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate

2001
Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo.
    Synapse (New York, N.Y.), 2003, Dec-15, Volume: 50, Issue:4

    Topics: Action Potentials; Adrenergic Uptake Inhibitors; Amygdala; Animals; Antidepressive Agents, Tricyclic; Binding, Competitive; Desipramine; Electrochemistry; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Imipramine; In Vitro Techniques; Locus Coeruleus; Male; Microelectrodes; Norepinephrine Plasma Membrane Transport Proteins; Pyridines; Radioligand Assay; Rats; Receptors, Kainic Acid; Symporters; Time Factors

2003
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:3

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Swimming; Thiazoles

2007
Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1

    Topics: Animals; Antidepressive Agents; Brain; Imipramine; Male; Mice; Mice, Knockout; Motor Activity; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Swimming; Thiazoles

2006
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
    Neuropharmacology, 2014, Volume: 84

    Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Hippocampus; Imipramine; Male; Moclobemide; Morpholines; Pyridines; Radioligand Assay; Rats, Wistar; Reboxetine; Receptor, Metabotropic Glutamate 5; Thiazoles; Tritium

2014